Not Yet Recruiting
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
NCT07192471
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- University of California, Irvine Medical Center - Hematology/Oncology Orange, California, United States
- Stanford University School of Medicine Stanford, California, United States
- Beth Israel Deaconess Medical Center - Research Boston, Massachusetts, United States
- Washington University School of Medicine - Oncology Hospital - Public St Louis, Missouri, United States